Rybelsus
Product Images NDC 0169-4804

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Rybelsus (NDC 0169-4804). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novo Nordisk Pharmaceutical Industries, Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural_formula (Structural Formula)

Chemical structure diagram depicting a peptide sequence with labeled amino acids and an attached lipid chain at Lys26. This structure likely represents the active ingredient associated with RYBELSUS tablets by Novo Nordisk Pharmaceutical Industries, LP.*

FDA Label Image

Figure_1 (Figure 1)

A line graph comparing the percentage of patients with events over time between RYBELSUS and placebo groups. The x-axis represents time from randomization in months (0 to 60), and the y-axis shows the percentage of patients with events (0% to 20%). The graph includes hazard ratio data (HR: 0.86, 95% CI: 0.77-0.96).*

FDA Label Image

Ozempic_1_5_carton (Ozempic Carton 1 5mg)

Carton label for OZEMPIC (semaglutide) Tablets 1.5 mg, containing 30 tablets. The label includes dosage and storage instructions, a pharmacist note on individual strengths of semaglutide, a reminder to dispense with medication guide, and manufacturer details for Novo Nordisk Pharmaceutical Industries, LP. The package also features a barcode and a patent information URL.*

FDA Label Image

Ozempic_4mg_carton (Ozempic Carton 4mg)

Packaging label for OZEMPIC (semaglutide) Tablets 4 mg by Novo Nordisk Pharmaceutical Industries, LP. The carton includes dosing instructions, patient usage tips, and storage conditions. It indicates a 30-tablet bottle and notes the new formulation of semaglutide. The label also provides pharmacist guidance about individual strengths and features manufacturer and contact information, along with a barcode.*

FDA Label Image

Ozempic_9mg_carton (Ozempic Carton 9mg)

The packaging label for OZEMPIC (semaglutide) tablets, 9 mg strength, by Novo Nordisk Pharmaceutical Industries, LP. It contains 30 tablets. The label includes dosage warnings, storage instructions, and a note that individual semaglutide strengths are not interchangeable on a mg-to-mg basis. The label also states the product is prescription only (Rx only) and to dispense with a medication guide.*

FDA Label Image

Rybelsus_3mg_carton (Rybelsus 3mg Carton)

Carton label for RYBELSUS 3 mg (semaglutide) tablets by Novo Nordisk Pharmaceutical Industries, LP. The label indicates oral use, once daily dosage, and includes 30 tablets. Instructions emphasize taking on an empty stomach with no more than 4 ounces of water and waiting 30 minutes before eating or other medications. Storage and patent information, barcode, and trademark details are also present.*

FDA Label Image

Rybelsus_7mg_carton (Rybelsus 7mg Carton)

RYBELSUS 7 mg tablets packaging label by Novo Nordisk Pharmaceutical Industries, LP. The label highlights the active ingredient semaglutide, indicates a 7 mg strength, and instructions including 'Once daily,' 'Oral use only,' and 'Rx only.' The package contains 30 tablets and features storage and usage instructions, including taking on an empty stomach and waiting 30 minutes before eating or drinking. A barcode and contact information for the manufacturer are also visible.*

FDA Label Image

Rybelsus_14mg_carton (Rybelsus 14mg Carton)

Packaging label for RYBELSUS 14 mg (semaglutide) tablets, manufactured by Novo Nordisk Pharmaceutical Industries, LP. The label indicates a 30-tablet package for oral use, taken once daily. The label includes usage instructions such as taking on an empty stomach with no more than 4 ounces of water and waiting 30 minutes before eating or taking other medications. Storage instructions and ingredients are also detailed.*

FDA Label Image

Rybelsus_3mg_blister (Rybelsus 3mg Blister)

Packaging label for RYBELSUS 3 mg (semaglutide) tablets by Novo Nordisk Pharmaceutical Industries, LP. The label states the strength as 3 mg, with oral use only, taken once daily. The package contains 30 tablets in 3 blister packs of 10 tablets each. It includes instructions to dispense the enclosed medication guide to each patient and contact information for healthcare questions.*

FDA Label Image

Rybelsus_7mg_blister (Rybelsus 7mg Blister)

Packaging label for RYBELSUS 7 mg (semaglutide) tablets, oral use only, with 30 tablets in 3 blister packs of 10 tablets each. The label shows the Novo Nordisk logo and instructions to dispense the enclosed medication guide. It indicates once daily dosing and is marked Rx only.*

FDA Label Image

Rybelsus_14mg_blister (Rybelsus 14mg Blister)

Packaging label for RYBELSUS 14 mg (semaglutide) Tablets by Novo Nordisk Pharmaceutical Industries, LP. The box contains 30 tablets in 3 blister packs of 10 tablets each. The label states oral use only, once daily dosage, and Rx only status with instructions to dispense the enclosed medication guide to patients.*

FDA Label Image

R2_1_5mg_carton (R2 1 5mg Carton)

Packaging label for RYBELSUS 1.5 mg semaglutide tablets by Novo Nordisk Pharmaceutical Industries, LP. The label indicates this is a sample, not for resale, with 30 tablets per bottle. It includes usage instructions, storage conditions, and a note to pharmacists that individual strengths of Rybelsus are not substitutable on a mg-to-mg basis.*

FDA Label Image

R2_4mg_carton (R2 4mg Carton)

RYBELSUS 4 mg (semaglutide) Tablets packaging label in a carton format by Novo Nordisk Pharmaceutical Industries, LP. The label includes dosage instructions, pharmacist notes, storage conditions, and patient information. The package contains 30 tablets and emphasizes taking on an empty stomach with limited water and waiting 30 minutes before eating or other medications. The design features a red and white color scheme with the Novo Nordisk logo and barcode.*

FDA Label Image

R2_9mg_carton (R2 9mg Carton)

RYBELSUS 9 mg (semaglutide) tablets packaging label from Novo Nordisk Pharmaceutical Industries, LP. The label features dosage information, instructions to take the tablet on an empty stomach with no more than 4 ounces of water, and to wait 30 minutes before eating or taking other medications. It states the bottle contains 30 tablets and highlights that individual strengths of Rybelsus are not substitutable on a mg-to-mg basis. The label includes storage instructions, manufacturer information, a barcode, and the Novo Nordisk logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.